# SwasthyaSetu AI — Pre-P22 Platform Security, Privacy, Retention and Resilience Readiness Pack

**Work unit:** `PRE-P22-PLATFORM-SECURITY-PRIVACY-RESILIENCE-READINESS` — documentation and accountable review **ONLY**.

**Repository:** `Itsbhavesh1101/swasthyasetu_ai`

**Verified starting `main` SHA:** `09200acdf5f824a335781249f6a8e56e47b68fcb`

**Merged predecessor:** PR **#51**, feature head `aeaef276de5fa6c8e4b5dc2b0d8fc528b220a473`; merge commit `09200acdf5f824a335781249f6a8e56e47b68fcb` is tree-equivalent to its reviewed feature head (the comparison has **zero changed files**). Pre-P21 produced an unsigned reconciliation docket, **not** privileged admin functionality or human approval.

**Suggested branch:** `phase/pre-p22-platform-security-privacy-readiness`

**Mandatory repository truth:** P22 and its future work units P22-A/B/C/D/E are **NOT STARTED**. Existing `docs/26_PRIVACY_CONSENT_SPEC.md` provides a privacy baseline; `docs/27_SECURITY_ARCHITECTURE.md` and `docs/28_THREAT_MODEL.md` are **P11-FOCUSED DRAFTS**, explicitly **not** a completed platform-wide architecture/threat model. `docs/30_TESTING_STRATEGY.md` and `docs/33_ERROR_HANDLING_POLICY.md` exist with their recorded scope; `docs/31_OBSERVABILITY_SPEC.md` and `docs/32_DEVOPS_DEPLOYMENT.md` are absent/not started according to the tracker. Do not overwrite, duplicate, or retroactively reclassify these existing sources. The tracker records P22 NOT STARTED, and all **AC-P22-001..011 remain LIVE NOT VERIFIED** at platform/pilot level, even where bounded engineering tests or scanners pass.

**Safety status to preserve:** P7 deterministic manual text/touch intake and generic urgent-help navigation remain the available patient path. P8-C/P9-C patient-facing Stage 3 **BLOCKED**; P10/P11 live approval **0/9** each (P11 five OPEN/four BLOCKED); P12–P21 runtime **NOT STARTED** where applicable; P13 real registry/referral and P14 clinical mental-health routing not approved; P15 clinical/source STOP remains; P16 FHIR and P17 ABDM live exchange unauthorized; P18 has no approved classical benchmark, P19 no comparator; P20 orchestration and P21 admin runtime not started; P23/P24 pilot/release not started. Do not construe any detached synthetic safety or document fixture as clinical approval. Alembic remains `p7a_0007`; Next.js and root `eslint-config-next` remain `16.4.2`.

> **HARD STOP:** This task must not change runtime code, tests, API routes, ORM/schema/migrations, dependency manifests/lockfiles, CI workflows, scanners, Docker/infrastructure, accepted ADRs, patient/clinician UI, feature flags, retention jobs, kill switches, credentials, or any live clinical/security/identity/consent policy. Do not inspect real patient data, upload medical documents, call external providers or production systems, carry out penetration testing, or claim regulatory compliance. Documentation, CI, scanners and synthetic tests do **not** constitute signed clinical, institutional, security, privacy, legal, pilot or production approval.

## 0 — Preflight, source precedence and existing-document protection

1. `git fetch` and independently verify local `main` and `origin/main` are **exactly** `09200acdf5f824a335781249f6a8e56e47b68fcb`; verify PR #51 is merged at that SHA and the reviewed head is tree-equivalent. Verify the two proposed P22 documents below are absent. If the baseline, tree or expected files differ, **STOP and report**. Do not silently rebase, reset, force-push, clean, overwrite, or modify unrelated worktrees. Create a new clean isolated worktree from that exact main and one new branch.
2. Read `docs/codex/CODEX_INSTRUCTIONS.md`, `CODEX_WORKFLOW.md`, and `CODEX_CONTEXT_RULES.md` plus `docs/00_PROJECT_MASTER_SPEC.md`, `01_PRODUCT_REQUIREMENTS.md`, `02_SYSTEM_ARCHITECTURE.md`, `03_REPOSITORY_STRUCTURE.md`, `04_DOMAIN_MODEL.md`, `05_DATABASE_SCHEMA.md`, `06_API_CONTRACTS.md`, `07_CLINICAL_INTAKE_SPEC.md`, `08_SAFETY_AND_TRIAGE_POLICY.md`, `09_MENTAL_HEALTH_POLICY.md`, `12_CLINICAL_PROVENANCE_SPEC.md`, `13_AI_ORCHESTRATION_SPEC.md`, `15_DOCUMENT_AI_OCR_SPEC.md`, `22_UX_AND_USER_FLOWS.md`, `23_PATIENT_APP_SPEC.md`, `24_CLINICIAN_DASHBOARD_SPEC.md`, `25_ADMIN_PORTAL_SPEC.md`, `26_PRIVACY_CONSENT_SPEC.md`, `27_SECURITY_ARCHITECTURE.md`, `28_THREAT_MODEL.md`, `29_ENGINEERING_STANDARDS.md`, `30_TESTING_STRATEGY.md`, `33_ERROR_HANDLING_POLICY.md`, `34_MASTER_IMPLEMENTATION_PLAN.md`, and applicable P11 security/privacy/consent readiness documents. Check actual paths before citation. Where a prior source is an unapproved draft, label it accurately. Do not invent missing `31`/`32` specifications.
3. Read `docs/implementation/35_PHASE_ACCEPTANCE_CRITERIA.md`, `36_DEPENDENCY_MAP.md`, `37_DECISION_LOG.md`, `38_PROGRESS_TRACKER.md`, P10/P11 live-readiness gates, P11-focused architecture/threat/privacy drafts, P13 and P21 administrative/source readiness, and latest P20 and P21 reconciliation documents. Accepted ADRs and canonical requirements control, especially ADR-001/002 modular ports, ADR-003 deterministic safety, ADR-006 outbox, ADR-008 PostgreSQL authority, ADR-010 provenance, ADR-012 governed longitudinal record, ADR-013 no universal score, ADR-020 staged flags, ADR-021 typed contracts, ADR-022 no invented clinical policy, ADR-027 independent degraded safety/manual paths, ADR-028 structured record authority, ADR-029 correction history, ADR-032/033 research/model separation, ADR-038 dependency profiles, ADR-039 trusted artifacts, and ADR-040 phase-gated infrastructure. Verify text/numbers against the decision log. **Do not modify or supersede ADRs.**
4. Inspect current repository code/config and CI **read-only**: P3 data/outbox/job/object-storage ports; P4 sessions/authz/consent/MFA primitives; P5 fact ownership; P6/P7 BFF/web/PWA/session cookie/no-store boundaries; P8/P9 synthetic-only restrictions; P10/P11/P13/P21 placeholders/detached contracts; existing tests, CI scans, Docker, environment/config patterns, application logging and rate-limit/error middleware if present. Distinguish implemented controls from unreviewed proposals and from absent infrastructure. Do not run live vulnerability scans/probes against endpoints; only safe local checks already approved in the repo.
5. Confirm canonical text **verbatim**: `AC-P22-001..011` from `docs/implementation/35_PHASE_ACCEPTANCE_CRITERIA.md`; `NFR-SEC-001..014`, `PRIV-001..009`, `NFR-RES-001..007`, and `FR-AUDIT-001..007` from `docs/01_PRODUCT_REQUIREMENTS.md`. Carry `SHALL`, `MUST`, `SHOULD`, `MAY` semantics intact. Cross-reference `FR-CONSENT-001..009`, `SAFE-001..010`, `FR-CORE-004/005/007/008/010`, `NFR-TEST-*`, `NFR-OBS-*`, P20/P21 and P23/P24 acceptance only where relevant. **Do not invent `FR-P22-*` IDs or a project-approved P22 gate count.**

## 1 — Deliverable A: platform-wide baseline and gap assessment (NEW)

Create **`docs/implementation/P22_PLATFORM_SECURITY_PRIVACY_GAP_ASSESSMENT.md`**. Title **Pre-P22 — Platform-Wide Security, Privacy, Retention, Resilience: As-Built/Gaps and Threat-Surface Inventory**. Header: **DRAFT — CURRENT-STATE RECONCILIATION ONLY; EXISTING SPECS 26/27/28 ARE NOT REPLACED; NO COMPLETED P22 THREAT MODEL OR SECURITY APPROVAL**. Record review date, exact main baseline, document hierarchy, accountable owner-role classes and evidentiary limits.

### A. Evidence map and scope

- Table existing Spec 26 (P4–P7 privacy baseline and future provider/retention decisions), Spec 27/28 (**P11-only** security/threat drafts), Specs 29/30/33, absent Docs 31/32, latest P21 decision docket, real source/test/CI primitives and P22-A..E intended work. For each: file/path, baseline evidence, observed implemented/absent status, coverage boundary, owner, missing proof and whether it is an **open review question**. Avoid reproducing lengthy existing documents; cross-reference them.
- Distinguish **IMPLEMENTED AND BOUNDED TECHNICAL CONTROL**, **SYNTHETIC/DETACHED TEST EVIDENCE**, **PROPOSED UNAPPROVED CONTROL**, **ABSENT**, **HUMAN DECISION PENDING**, and **LIVE NOT VERIFIED**. Green CI, current scanner success, typed permissions, a config flag or P11 mock does not mean cross-platform security acceptance or production readiness. Do not claim the mere P11 threat-model file satisfies the platform-wide scope of `AC-P22-001`.
- Enumerate actual trust zones and data classes: patient browser/PWA/cache, patient BFF/cookies, FastAPI, actor/role/institution/consent, PostgreSQL/transaction/outbox, local versus production object storage, jobs/workers, clinician/admin apps, external LLM/OCR/speech/providers/referrals, FHIR/ABDM, research ML/QML, RAG/embedding, monitoring/audit/backups/deployment. Mark absent systems FUTURE, not active. Keep no-invented-identity/consent and raw clinical narrative boundaries explicit.

### B. Control and attack-surface delta matrix

Create a **platform-wide gap/control matrix**, without silently editing `27_SECURITY_ARCHITECTURE.md` or `28_THREAT_MODEL.md`. For each item supply: trust boundary/asset; threat or misuse case (STRIDE-inspired where appropriate); source/actual repo evidence; proposed control (unapproved); current state (implemented bounded / missing / blocked / needs verification); affected canonical ID(s); accountable owner; required evidence/test; residual/unknown risk; STOP implication. Cover at minimum:

1. **Identity and scoped authorization:** pseudonymous session vs authenticated production actor, verified IdP and actual MFA ceremony (not a boolean), service accounts, privileged admin/clinician/source roles, object/patient/institution/assignment/purpose checks; IDOR, role/header/MFA forgery, client-side trust, user enumeration, revoked relationships; deny-by-default and nonenumeration.
2. **Web/API protections:** TLS, secure cookies, browser/Next BFF, CSP and headers, CSRF where cookie authentication applies, CORS, XSS and malicious external links, schema/bounds/content rendering, abuse/rate limiting, denied scopes, safe errors, no-store and PWA cache discipline; differentiate current controls from absent pilot hardening.
3. **File and optional AI/external boundaries:** hostile upload MIME/bytes/size, quarantine/scanner/storage/key grants, parser/OCR/LLM prompt injection, untrusted knowledge retrieval, supplier/provider region/data transfer, sandbox endpoints, retries/callback/webhooks, minimized data/egress and credential ownership. P11 and other unused adapters stay disabled; no provider onboarding or live test.
4. **Consent, privacy, data lineage and separation:** explicit purpose/nontransitive consent including `REFERRAL_SHARING`, research data segregation, pseudonymous mode, patient facts versus unconfirmed extraction, source/version, tenant/institution scope; wrong-patient/wrong-purpose, consent withdrawal mid-flight, cross-border/vendor access; no raw sensitive payload in logs, analytics, cache, URLs or service errors.
5. **Retention, deletion, legal hold, derived data and restore:** policy required for each actual/future data class and system (DB/events/outbox/object binary/derived OCR/text/vector/cache/telemetry/backup/provider/worker), purpose, source, owner and lawful basis; no guessed durations or legal conclusions. Proposed tombstone/generation, idempotent purge, partial failure, observability, restore reconciliation, legal hold and revocation races. **No purge worker/job or deletion operation is implemented this phase.**
6. **Audit, observability, secrets and access:** closed/minimized event schema, audit-of-audit, tamper evidence, role-scoped viewer, no raw transcript search, breach/incident evidence, key/secret location/rotation, scanner scope and CI artifacts; don't conflate transactional outbox with product-wide immutable audit store.
7. **Resilience and feature isolation:** DB as required dependency vs LLM/OCR/speech/referral/provider/FHIR/ABDM/model/RAG as optional or stage-blocked, dependency timeouts and bounded retries, idempotency/race handling, kill-switch ownership, user-visible degraded mode, critical P7 manual route and generic urgent-help availability. Existing safe-off flags are not verified P22 kill-switch acceptance for unimplemented high-risk paths.
8. **Supply chain, environment and release:** locked dependencies, license/advisory scanning, Gitleaks, Trivy/container metadata warnings, least-privilege images, GitHub Actions controls, artifact provenance/signing, secret leakage, backup/restore/incident response, SLOs; separate observed scan evidence from risk closure and P24 pilot signoff.

Include **no fabricated severity acceptance**, no invented cryptographic choices/key lengths, retention periods, abuse thresholds, data protection guarantees, vendor agreements, clinical policy, or 'all threats mitigated' language. Risks remain OPEN/BLOCKED pending accountable review. Note that prior security CI logs include a **Trivy metadata retrieval warning for `CVE-2026-107891`** while the job succeeded; this is not proof of an exploitable issue or proof that it is resolved. Request an owner review of scanner evidence/DB freshness and a future documented disposition without changing scanner settings or declaring vulnerability status.

### C. Verification backlog and phased boundary

- A prioritizable backlog for later approved **P22-A** platform threat model/authz inventory; **P22-B** narrowly scoped security controls; **P22-C** retention/deletion and restore; **P22-D** independently controlled kill switches/failure isolation; **P22-E** full security regression tests. Include dependency, accountable signer, negative/adversarial test and evidence artifact, **NOT STARTED**. P22-A's proposed update to `docs/28_THREAT_MODEL.md` is a *future approved change*; existing P11-specific history remains unchanged in this docs-only PR.
- Threat/evidence examples: cross-subject IDOR, fraudulent MFA/roles, consent withdrawal during dispatch, expired verification, forged webhook, malicious document, injected RAG/tool response, compromised model artifact, secret/PII telemetry canary, duplicate retry, partial purge, backup restore resurrection, optional-model outage, hostile uploaded content, rate limit bypass, release flag bypass, rollback/incident failure. These are a **proposed plan**, not tests already run or clinically approved oracles.
- Explicit **STOP** before any real patient processing beyond existing P7 scope, security-policy change, privileged action, provider/referral data, external transmission, live file processing, retention execution, rollout, pilot or production approval.

## 2 — Deliverable B: accountable P22 readiness review (NEW)

Create **`docs/implementation/P22_READINESS_GATE_REVIEW.md`**. Header: **DRAFT — DESCRIPTIVE ACCOUNTABLE SECURITY/PRIVACY/RESILIENCE REVIEW DOMAINS, NOT AN OFFICIAL GATE COUNT OR P22 IMPLEMENTATION/RELEASE AUTHORIZATION**. Date/baseline/source hierarchy. Include **eight descriptive OPEN/BLOCKED domains** matching the control areas above, with each domain documenting actual repo proof, missing decisions, accountable **roles** not invented names, unapproved control options, evidence required, adversarial/negative tests, residual risk, failure/safe-off, and explicit STOP. No `0/8 approved`, do not import P10/P11 official nine-gate arithmetic.

The eight review domains should be:

1. Production identity, object/institution authorization, privileged MFA and sessions.
2. Browser/BFF/API security, injection/XSS/CSRF, rate limiting and hostile uploads.
3. Purpose/consent/data minimization, external AI and integration egress.
4. Retention, withdrawal/deletion, derived copies, provider deletion, legal holds and backup/restore.
5. Audit, logs/traces/metrics, no raw sensitive search, evidence integrity and incident monitoring.
6. Dependency outages, timeouts, feature kill switches, recoverability and P7/urgent-help independence.
7. Secrets, supply chain, scanners, container/CI infrastructure, evidence ownership and signed dispositions.
8. Platform-wide threat model, independent security/privacy reviews, incident/rollback, bounded pilot and P22/P23/P24 release gate.

Include an **unsigned scoped decision template** (decision ID; phase/unit/domain; asset/system; exact subject/object/actor/institution and purpose; approved authority vs absent; evidence hash/code/build SHA/test run; threat severity rubric if independently approved; alternatives; risk owner; residual risk; reviewer name/independence; date/expiry/re-review; rollback/withdrawal/incident; signatures **PENDING**) and an owner/risk register. Do not assign actual individuals or sign decisions.

### Exact requirements and acceptance traceability

- In at least one of the two new deliverables, reproduce **verbatim from current repo**, ID by ID: **all 11 `AC-P22-001..011`**, **14 `NFR-SEC-001..014`**, **9 `PRIV-001..009`**, **7 `NFR-RES-001..007`**, and **7 `FR-AUDIT-001..007`**. For each record source, baseline as-built evidence (if any), impacted control/domain, missing decision/test/artifact, responsible reviewer and correct LIVE status; `AC-P22` entries must all be **LIVE NOT VERIFIED**. Do not claim `AC-P22-001` is passed merely because the P11-specific `28_THREAT_MODEL.md` exists; nor `AC-P22-003` because Gitleaks found no leaks in one CI run; nor upload/retention/kill-switch acceptance for disabled/unimplemented capabilities. A locally verified narrower safeguard may be recorded as **BOUNDED TECHNICAL EVIDENCE — NOT P22 ACCEPTANCE**.
- Preserve SHALL/MUST/SHOULD/MAY. Clearly flag `AC-P22-011` human acceptance as future conditional pilot decision: no high/critical finding may be silently waived or declared accepted based on this review, CI or an LLM statement. Formal bounded acceptance requires a real accountable risk owner, scope, expiry, safeguards and evidence.
- Related P7/P8/P9/P10/P11/P13/P14/P15/P16/P17/P18/P19/P20/P21 and P23/P24 gates remain separately owned. `PRIV-003`/`004` are not satisfied by retention ideas; `NFR-SEC-006` is not satisfied by P11 paper design; `NFR-SEC-003` is not satisfied by `mfa_verified` synthetic checks; audit viewers are not built. No policy, scientific, regulatory or pilot signoff inferred.
- **Final STOP and owner action:** named qualified clinical/safety, identity/institution, security/appsec, privacy/legal/records, data governance, accessibility/product, platform/SRE, incident, research/interop/vendor and release owners must review the current threat/data-flow evidence and sign exact bounded decisions. Only a **new separately authorized P22-A prompt** may perform a safe non-invasive threat/authz audit; P22-B/C/D/E implementation, P23/P24, pilot and release are not authorized by this document.

## 3 — Exactly four authorized paths and progress tracker

**Change exactly these four documentation paths, no others:**

```text
docs/implementation/P22_PLATFORM_SECURITY_PRIVACY_GAP_ASSESSMENT.md         # NEW; gap/evidence matrix
docs/implementation/P22_READINESS_GATE_REVIEW.md                           # NEW; unsigned accountable review
docs/implementation/38_PROGRESS_TRACKER.md                                # existing P22 note + #68 ONLY
docs/codex/CODEX_PHASE_PROMPTS/PRE_P22_SECURITY_PRIVACY_RETENTION_RESILIENCE_READINESS_PACK.md  # byte-identical copy of THIS provided prompt
```

In `docs/implementation/38_PROGRESS_TRACKER.md`:

- Update **only** the P22 macro phase-table row's **Notes**, leaving its **Status `NOT STARTED`** unchanged. E.g., `Pre-P22 platform-wide gap assessment and unsigned readiness dossier drafted; P22-A/B/C/D/E NOT STARTED, AC-P22-001..011 LIVE NOT VERIFIED, accountable decisions pending.` Keep all other phase rows and the current project-status narrative untouched.
- Leave `Before hardening` document rows **unchanged**, especially Spec 27/28 **P11-FOCUSED DRAFT**, Spec 26 baseline, and missing Specs 31/32. Do not convert their current statuses to COMPLETE. Leave all existing specs/readiness files, ADRs and sections 1–67 untouched.
- Append **exactly** `# 68. Pre-P22 Platform Security, Privacy, Retention and Resilience Readiness Pack`, with a bounded record of base SHA/PR #51 tree equivalence; existing P11-focused Docs 27/28 and other document statuses; new gap/decision artifacts; 8 descriptive domains not official gates; exact `AC-P22-001..011`/NFR/PRIV/AUDIT crosswalk; all P22 live acceptance NOT VERIFIED; P22-A/B/C/D/E NOT STARTED; upstream clinical and privacy STOPs; Alembic, dependency, Next.js and CI unchanged; no runtime, policy or approval; accountable owner review and next authorized prompt only.

**Prohibited:** editing `docs/26_PRIVACY_CONSENT_SPEC.md`, `docs/27_SECURITY_ARCHITECTURE.md`, `docs/28_THREAT_MODEL.md`, `docs/31_OBSERVABILITY_SPEC.md`, `docs/32_DEVOPS_DEPLOYMENT.md` or any other non-allowlisted file; changing existing CI scanner policy, suppression, vulnerable dependencies, runtime auth/authorization/consent, cookies, CSP/CSRF/CORS, actual rate limits, upload scanning, retention/deletion/purge, logging, encryption, observability, secrets, IAM/service roles, Docker/Compose, storage/backups, deployment, release flags, clinical rules, signed approvals, schema/ORM/migrations, APIs, UIs, fixtures, tests, local patients or production systems. No exploitation, active vulnerability scanning, external endpoint probing or real data. Stop and report any additional requirement.

## 4 — Validation, GitHub PR and handoff

1. Verify requirement **verbatim** against canonical docs, correct 11/14/9/7/7 coverage, honest evidence categorization, architecture/source cross-links, P11-only Docs 27/28 unchanged, no invented risk acceptance or retention durations, status vocabulary and 8 descriptive domains. Check strict four-path allowlist, section `# 68.` uniqueness, status P22 NOT STARTED, and `git diff --check`.
2. Run appropriate Markdown Prettier on **new docs**; if the existing tracker has historical full-file formatting differences, format-check the changed content without rewriting unrelated historical lines and report the warning rather than expanding scope. Verify prompt file is **byte-for-byte identical** to this file. No `.env`, generated files, personal identifiers, test data, service tokens, snapshots or dependency changes. Run Gitleaks for source-controlled content and the **exact new commit range** without weakening scanners; distinguish generated venv/Next artifacts from committed files and report warnings honestly.
3. Run existing local backend/frontend/static/type/format quality checks and, when feasible, real PostgreSQL, Playwright and Docker checks; truthfully record pass/fail/skip/retry/environment warnings. **All six GitHub CI jobs must report SUCCESS on exact final PR head SHA:** Backend quality, Frontend quality, Persistence integration, Docker and PostgreSQL, Playwright Chromium, Security scans. A passing scanner or test proves only what it actually tested; it does **not** close P22 acceptance, legal obligations, risk acceptance or clinical release gates.
4. One isolated branch, one clean commit from exact verified baseline, one PR. Confirm final local SHA = remote branch SHA = PR head = CI run SHA. **DO NOT MERGE.** No P22-A/B/C/D/E runtime, no P23/P24, no revised ADR or consent. Stop after opening PR and return:

```text
STATUS: COMPLETE PRE-P22 DOCUMENTATION ONLY / PARTIAL / BLOCKED
BRANCH: phase/pre-p22-platform-security-privacy-readiness
BASE MAIN SHA: 09200acdf5f824a335781249f6a8e56e47b68fcb
FINAL LOCAL SHA:
FINAL REMOTE SHA:
PR URL / NUMBER:
PR #51 MERGE BASE/TREE VERIFIED:
EXISTING SPEC 26/27/28/30/33, MISSING 31/32 — AS-BUILT VS PROPOSED:
P22 PLATFORM GAP ASSESSMENT / THREAT AND CONTROL MATRIX:
P22 READINESS — EIGHT DESCRIPTIVE DOMAINS / UNSIGNED DECISIONS / STOP:
AC-P22-001..011, NFR-SEC-001..014, PRIV-001..009, NFR-RES-001..007, FR-AUDIT-001..007 EXACT TRACEABILITY:
IDENTITY/MFA, BFF/API, UPLOAD, CONSENT, RETENTION/DELETION, AUDIT, SECRETS, KILL SWITCHES:
EXISTING CI/SCANNER EVIDENCE VS LIVE P22 ACCEPTANCE / VULNERABILITY WARNINGS:
UPSTREAM GATES / P22-A..E NOT STARTED / HUMAN APPROVALS PENDING:
CHANGED PATHS / TRACKER HEADING 68 / PROMPT BYTE EQUIVALENCE:
ALEMBIC / DEPENDENCIES / CI / OTHER FILES UNCHANGED:
LOCAL QUALITY / GITLEAKS / WARNINGS / RETRIES:
CI RUN / EXACT FINAL SHA / SIX JOB CONCLUSIONS:
MERGED: NO
```

> **FINAL STOP:** This pack prepares an accurate cross-platform control/threat delta and review docket. It does not substitute for the future independent platform-wide threat assessment, implement security hardening or retention, resolve a vulnerability, authorize patient/clinical/admin integrations, satisfy live P22 acceptance, grant any human signature, or approve a pilot/production deployment.
